cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Vaxxinity Inc
5 own
6 watching
Current Price
$0.44
$-0.01
(-1.39%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
250.85M
52-Week High
52-Week High
3.10000
52-Week Low
52-Week Low
0.39110
Average Volume
Average Volume
0.44M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization250.85M
icon52-Week High3.10000
icon52-Week Low0.39110
iconAverage Volume0.44M
iconDividend Yield--
iconP/E Ratio--
What does the Vaxxinity Inc do?
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer s disease (AD) that is in phase 2 clinical trial; UB-312 that targets toxic forms of aggregated a-synuclein in the brain to fight Parkinson's disease and other synucleinopathies, such as Lewy body dementia and multiple system atrophy that is in phase 1 clinical trial; and an anti-tau product candidate for various neurodegenerative conditions, including AD. It is also developing UB-313 that targets calcitonin gene-related peptide to fight migraines; anti-PCSK9 that targets proprotein convertase subtilisin/kexin type 9 serine protease to lower low-density lipoprotein cholesterol and reduce the risk of cardiac events; and UB-612 for neutralizing the SARS-CoV-2 virus, which is in phase 3 clinical trial. Vaxxinity, Inc. was founded in 2014 and is headquartered in Dallas, Texas.
Read More
How much money does Vaxxinity Inc make?
News & Events about Vaxxinity Inc.
Globe Newswire
1 year ago
CAPE CANAVERAL, Fla., March 27, 2023 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today reported financial results for the fourth quarter and full year ended December 31, 2022. We are grateful for and ...
Globe Newswire
1 year ago
CAPE CANAVERAL, Fla., March 21, 2023 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, announced today that it has joined TransCelerate BioPharma, Inc. (TransCelerate) as the first emerging biotechnology ...
Globe Newswire
1 year ago
CAPE CANAVERAL, Fla., March 20, 2023 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today announced that the first subjects have been dosed in a randomized, double-blind, placebo-controlled Phase 1 clinical ...
Globe Newswire
1 year ago
Vaxxinity to present new preclinical data on anti-tau Alzheimers vaccine candidate VXX-301 at AD/PD International ConferenceCAPE CANAVERAL, Fla., March 02, 2023 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines...
Globe Newswire
1 year ago
Appointment of new directors bring diversity, balance and relevant industry expertise to Vaxxinity Establishment of Frontier Exploration Laboratories (VaxxLabs) in Cape Canaveral, Fla., as corporate headquarters CAPE CANAVERAL, Fla., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), ...
Frequently Asked Questions
Frequently Asked Questions
What is Vaxxinity Inc share price today?
plus_minus_icon
Can Indians buy Vaxxinity Inc shares?
plus_minus_icon
How can I buy Vaxxinity Inc shares from India?
plus_minus_icon
Can Fractional shares of Vaxxinity Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Vaxxinity Inc stocks?
plus_minus_icon
What is today’s traded volume of Vaxxinity Inc?
plus_minus_icon
What is today’s market capitalisation of Vaxxinity Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Vaxxinity Inc?
plus_minus_icon
What percentage is Vaxxinity Inc down from its 52-Week High?
plus_minus_icon
What percentage is Vaxxinity Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0.44
$-0.01
(-1.39%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00